MetaCap

Cumberland Pharmaceuticals (CPIX) vs Organigram Global (OGI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cumberland Pharmaceuticals (CPIX) has outperformed Organigram Global (OGI) over the past year, gaining 193.5% versus a loss of 60.6%. Over five years, CPIX leads with a +161.9% price change compared with -93.3% for OGI. Cumberland Pharmaceuticals is the larger company by market cap ($87.6 million vs $82.3 million), about 1.1 times the size.

On valuation, Organigram Global trades at a lower forward P/E (27.8x vs 41.7x for Cumberland Pharmaceuticals).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX+193.47%OGI-60.61%
+371%+145%-81%
Nov 21, 20251 yearNov 20, 2026
CPIX+134.54%OGI-92.71%
+258%+74%-109%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus OGI key metrics
MetricCPIXOGI
Share price$5.84$0.583
Market cap$87.57M$82.27M
1-day change-7.30%-7.40%
YTD return+46.73%-65.30%
1-year return+193.47%-60.61%
5-year return+161.88%-93.25%
P/E ratio (TTM)—1.36
Forward P/E41.7127.76
EPS (TTM)$-0.57$0.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.52M—
Revenue growth (YoY)+17.57%—
Net income (latest FY)$-2.84M—
Gross margin85.02%—
Operating margin-6.27%—
Net margin-6.37%—
52-week high$9.28$2.24
52-week low$2.00$0.583
Distance from 52-week high-37.07%-73.97%
Analyst consensus—strong_buy
Average volume114.52K567.77K
Shares outstanding15.00M141.11M
Employees881,139
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CPIX has outperformed OGI by 254.1 percentage points over the past year.

About Cumberland Pharmaceuticals

CPIX stock →

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees

About Organigram Global

OGI stock →

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.

Health Care · Biotechnology: Pharmaceutical Preparations · 1,139 employees

CPIX vs OGI FAQ

Which is bigger, Cumberland Pharmaceuticals or Organigram Global?

Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $87.57M compared with $82.27M for Organigram Global (OGI).

Which stock has performed better over the past year, CPIX or OGI?

CPIX returned +193.47% over the past 12 months, compared with -60.61% for OGI (price return, excluding dividends). Past performance does not predict future results.

Are Cumberland Pharmaceuticals and Organigram Global in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons